Jeffrey S. Weinberg

Professor, Deputy Chair, Vice-Chair, Clinical Ops, Dept of #Neurosurgery, @MDAndersonNews, Job #1: Husband, Dad to 3 great kids. Tweets are my own.

[John Kahlooni Fans @JohnKahlooniQ]

THIS VIDEO FROM THE EPSTEIN FILES IS GOING VIRAL AS PEOPLE START TO REALIZE WHO THAT IS 😳

[Jeffrey S. Weinberg @DrJeffWeinberg]

Thrilled to publish the results of the ROADS trial for newly dx’d brain mets requiring surgery. The results define a new standard. Congrats Dr. Beckham and all co-authors! @jco_asco
@UTMDAnderson @ASCO #oncsurgery https://t.co/Yr3mvb9NKS @NSTumorSection

[UT MD Anderson @UTMDAnderson]

Now published in @JCO_ASCO, Phase 3 ROADS trial findings show tile-based radiation therapy delivered during surgery significantly improved tumor control and more than doubled median overall survival in patients with brain metastases.

Read more: https://t.co/lWgxUrXcCv #EndCancer @DrJeffWeinberg

[Jeffrey S. Weinberg @DrJeffWeinberg]

Read how the results of the ROADS trial impacts patient care. @asco #asco2026 @brandon_imber @Dr_N_Moss @KimberlyBHoang @patelnv @AlexandraPaulMD @NSTumorSection @LindseySloan19 #oncsurgery @HTawbi_MDPhD #endcancer

[UT MD Anderson @UTMDAnderson]

After joining a clinical trial for a new tile-based form of brachytherapy at UT MD Anderson, Stacy Dixon is now cancer-free following stage 4 melanoma with brain metastases.

Research presented at #ASCO26 highlights how this approach may help improve treatment for patients with brain metastases. https://t.co/jXtPT28pnx #EndCancer @DrJeffWeinberg

[HemOnc Today @HemOncToday]

🗨️ “Surprised and ecstatic.”

🩻 @DrJeffWeinberg @UTMDAnderson spoke with @GoHealio about findings from #ASCO2026 showing tile-based radiation significantly improved recurrence and survival for resected #BrainMetastases. https://t.co/aCaNKJ8nm7

[Moffitt Cancer Center @MoffittNews]

🚨New phase 3 data presented at the 2026 @ASCO Annual Meeting compared postoperative stereotactic radiation with cesium-131 tile-based radiation following resection of brain mets.

Peter Forsyth, MD (@PeterForsyth27), discusses the work by @DrJeffWeinberg of @UTMDAnderson.

[Jeffrey S. Weinberg @DrJeffWeinberg]

Thank you @ASCOPost for featuring our study! @asco #asco2026 #oncsurgery @brandon_imber @Dr_N_Moss @KimberlyBHoang @patelnv @AlexandraPaulMD @LindseySloan19 @NSTumorSection @UTMDAnderson https://t.co/mIiEctSSLA

[Jeffrey S. Weinberg @DrJeffWeinberg]

Our abstract was featured as potential standard changing therapy! Congratulations to my co-authors and collaborators! https://t.co/c0EKgJ23Lx @ASCO @NSTumorSection #oncsurgery #asco2026 @brandon_imber @Dr_N_Moss @KimberlyBHoang @patelnv @AlexandraPaulMD @LindseySloan19

[Jeffrey S. Weinberg @DrJeffWeinberg]

Very excited to attend my first @ASCO #asco2026 and release the exciting results of our phase 3 trial for patients requiring surgery for metastatic brain disease! @UTMDAnderson @NSTumorSection #oncsurgery

[Jeffrey S. Weinberg @DrJeffWeinberg]

@chandraankush @UTMDAnderson @CNSResidents @NSTumorSection We are the lucky ones! Looking forward to you joining our team! @NSTumorSection #oncsurgery

[UT MD Anderson @UTMDAnderson]

Sat. 12:15-12:45 p.m.

Advances in brain metastases care are creating new possibilities for patients. At #ASCO26, Drs. Hussein Tawbi and Jeffrey Weinberg will share updates on treatment approaches following surgery.

Join us at booth 13109 for the discussion. @DrJeffWeinberg @HTawbi_MDPhD #EndCancer 6/11

[The Yang Lab @TheYangLab1]

That’s a wrap on #aans2026! Thanks to @AANSNeuro for an outstanding conference - grateful for the insights, innovation, and incredible conversations shaping the future of neurosurgery. Excited to carry this momentum forward at #aans2027 in #sandiego 🧠🌊🌅

#aans photo - @IsaacYangMD @UCLANsgy @DrJeffWeinberg @MDAndersonnews @PPelargosMD @OU_Neurosurgery

@AANSDiversity @NSTumorSection @cvsection #Innovation #Collaboration #Transformation @UCLA_ENT @UCLAHealth @dgsomucla @HarborUCLA @HarborUCLASurg @HarborTrauma

[Chiba Ene @ChibaEne_MDPhD]

@FrederickLangMD interview with Dr. Jim Allison on his Nobel prize winning work on CTLA4 checkpoint inhibitors that cure previously fatal cancers like melanoma. Inspirational work that gives us hope for curing the currently fatal GBM @UTMDAnderson @txbraintrust @AANSNeuro

[Jeffrey S. Weinberg @DrJeffWeinberg]

Frederick Lang introducing and leading a Q&A with @UTMDAnderson own Nobel laureate Dr James P Allison as the @AANSNeuro 2026 Cushing Orator. #oncsurgery @NobelPrize @NSTumorSection @AANSNeurosurg

[Jeffrey S. Weinberg @DrJeffWeinberg]

@borgesmricardo @EberlinLab @MDAndersonNews @BCM_Surgery @BCMFromtheLabs Convince me? We worked hard to convince @livia__se we were worth the effort! We are so happy to be involved in this project and can't wait to enroll our next patient! Huge lift to finally get to this milestone. #oncsurgery

[Jeffrey S. Weinberg @DrJeffWeinberg]

Bittersweet zoom mtg celebrating career of our friend and founding chair, Dr Raymond Sawaya, who is retiring to move on to @AUB_Lebanon. We will miss him, his presence, mentorship and friendship. #oncsurgery @CNS_Update @AANSNeuro @NSTumorSection

[GammaTile by GT Medical Technologies, Inc. @GammaTile]

We're excited to announce that @DrJeffWeinberg enrolled the first patient in a multicenter, randomized controlled clinical trial evaluating #GammaTile in patients with metastatic brain tumors. Read the press release: https://t.co/uaXldp8OIJ
@MDAndersonNews
#Neurosurgery #btsm

[Jeffrey S. Weinberg @DrJeffWeinberg]

Honored to be featured in this months Brain Tumor Support Group panel alongside my outstanding colleagues, Rebecca Harrison and MaryFrances McAleer. Great way to play a role supporting (#punintended) #GoGrayinMay #BTAM #endcancer #oncsurgery @MDAndersonNews

[CERN Foundation @CERNfoundation]

It's Ependymoma Awareness Day!

Share this picture to your personal channel to create a greater understanding of the disease. #CERNButterfly

https://t.co/4OkOLLJAUW